百度李彥宏:中國AI市場即將迎來爆發性需求增長 商業價值前所未有
百度(BIDU.US)(09888.HK)宣布,即將在3月份推出新一代的大語言模型「文心一言」,它也是繼文心一格之後百度的又一個生成式AI產品。百度創始人、董事長兼首席執行官李彥宏在內部信表示,AI技術已經發展到一個臨界點,各行各業都不可避免地被改變。中國AI市場即將迎來爆發性的需求增長,其商業價值的釋放將是前所未有的、指數級的。
李彥宏內部信中介紹,百度計劃將多項主流業務與文心一言整合。文心一言與搜索整合,將引領搜索體驗的代際變革;文心一言將通過百度智能雲對外提供服務,根本性地改變雲計算市場的遊戲規則;此外,文心一言大模型還將搭載到Apollo智艙系列產品,並與小度進行集成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.